Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Alzheimer's Disease

Free Subscription 09.02.2026 19 Alzheimers Dement 1 Biochemistry 2 Curr Alzheimer Res 1 Curr Opin Neurol 2 Exp Gerontol 10 J Alzheimers Dis 1 J Biol Chem 1 J Neurol 1 Nat Med 1 Nature 1 Neurobiol Dis 3 Neurology 1 Neuroscience 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. PUECH C, Sadanand A, Coleman N, Ikhane M, et al
   APP-mediated intracellular signaling rescues sleep impairment and blood-brain barrier leakage in Alzheimer's disease mouse model.
   Alzheimers Dement. 2026;22:e71134.
   PubMed         Abstract available
   
   
2. PEYTON M, Jury-Garfe N, Liu J, Beimfohr C, et al
   Single-cell analysis reveals neuroprotective histone deacetylase inhibitor pathways.
   Alzheimers Dement. 2026;22:e71108.
   PubMed         Abstract available
   
   
3. CAI Y, Snitz BE, Cohen AD
   Associations between accelerometer-derived physical activity complexity, cognitive function, and plasma biomarkers of Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71181.
   PubMed         Abstract available
   
   
4. KIM S, Kremen S, Danovitch I, Lahiri S, et al
   Urinary tract infection-related delirium in Alzheimer's disease and related dementias: Clinical challenges and translational opportunities.
   Alzheimers Dement. 2026;22:e71184.
   PubMed         Abstract available
   
   
5. FALGAS N, Tort-Colet N, Martin-Sobrino I, Maya G, et al
   Relationship between locus coeruleus and slow-wave sleep in aging and Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71183.
   PubMed         Abstract available
   
   
6. MORCILLO-NIETO AO, Rozalem-Aranha M, Maure-Blesa L, Rodriguez-Baz I, et al
   Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome.
   Alzheimers Dement. 2026;22:e71157.
   PubMed         Abstract available
   
   
7. YE Q, Gao W, Feng J, Li X, et al
   Spatial heterogeneity in microglia-complement crosstalk: Implications for synaptic pruning in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71185.
   PubMed         Abstract available
   
   
8. 
   Correction to "The microbiota-gut-brain axis in mild cognitive impairment and Alzheimer's disease: A scoping review of human studies".
   Alzheimers Dement. 2026;22:e71221.
   PubMed        
   
   
9. FU X, Zhang J, Xiao Q, Li T, et al
   Deep cervical lymphatic-venous anastomosis attenuates cognitive dysfunction and biomarker abnormalities in severe Alzheimer's disease: A prospective single-arm study.
   Alzheimers Dement. 2026;22:e71150.
   PubMed         Abstract available
   
   
10. LOCKHART SN, Sutphen CL, Tanley J, Gonzalez-Ortiz F, et al
    Plasma and neuroimaging biomarkers of small vessel disease and Alzheimer's disease in a diverse cohort: MESA.
    Alzheimers Dement. 2026;22:e71131.
    PubMed         Abstract available
    
    
11. VAN DER VLIET D, de Vries LE, Di X, Wever D, et al
    Reduced triacylglycerols and lipid droplets are associated with resilience to Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71083.
    PubMed         Abstract available
    
    
12. DALLAIRE-THEROUX C, Denis HL, Cottez R, Tremblay C, et al
    Distinct alterations of adiponectin, fibroblast growth factor 21 (FGF-21), and insulin-like growth factor binding protein 2 (IGFBP-2) link dysmetabolism with cognitive decline across the Alzheimer's disease spectrum.
    Alzheimers Dement. 2026;22:e71097.
    PubMed         Abstract available
    
    
13. KANTARCI K, Kara F, Tosakulwong N, Fought AJ, et al
    Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial.
    Alzheimers Dement. 2026;22:e71067.
    PubMed         Abstract available
    
    
14. WEAR D, Morrone CD, Simpson D, Liu F, et al
    Sex-specific acceleration of Alzheimer's pathogenesis by chronic sleep-deprivation.
    Alzheimers Dement. 2026;22:e71099.
    PubMed         Abstract available
    
    
15. CHENG A, Zou Y, Liu L, Wang H, et al
    APOE4 and cognition in intracranial atherosclerosis: beyond Alzheimer's pathology.
    Alzheimers Dement. 2026;22:e71087.
    PubMed         Abstract available
    
    
16. GIARDINA SF, Culver A, Ahmed C, Mirescu C, et al
    From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs.
    Alzheimers Dement. 2026;22:e71165.
    PubMed         Abstract available
    
    
17. PUGH DA, Cary GA, Greathouse KM, Nassour-Caswell LC, et al
    NRN1 as a therapeutic target for Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71149.
    PubMed         Abstract available
    
    
18. KUSHWAHA S, Roy Choudhury R, Bhat P, Kumaran SS, et al
    Female-biased astrocytic priming shapes early locus coeruleus vulnerability in an Abeta oligomer milieu.
    Alzheimers Dement. 2026;22:e71168.
    PubMed         Abstract available
    
    
19. HOU XH, Zhang W, Kang K, Jin Y, et al
    Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns.
    Alzheimers Dement. 2026;22:e71106.
    PubMed         Abstract available
    
    

    
    Biochemistry

20. KASS B, Poschmann G, Demir F, Huesgen P, et al
    The Proteome of Human Amyloid Beta Oligomers.
    Biochemistry. 2026;65:339-353.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

21. RAUDINO F
    History of Senile Dementia from the Antiquity to the Beginning of the Modern Age.
    Curr Alzheimer Res. 2025;22:502-509.
    PubMed         Abstract available
    
    
22. MEHRABADI S, Barati S
    Exploring the Interconnections of Genetic, Lifestyle, and Epigenetic Influences on Brain Aging: A Comprehensive Review.
    Curr Alzheimer Res. 2025;22:488-501.
    PubMed         Abstract available
    
    

    
    Curr Opin Neurol

23. EYSERT F, Deportes G, Delaquaize E, Chami M, et al
    Peripheral alterations of mitochondrial function and mitophagy in Alzheimer's disease: from fundamental research to clinical perspectives.
    Curr Opin Neurol. 2026 Jan 30. doi: 10.1097/WCO.0000000000001457.
    PubMed         Abstract available
    
    

    
    Exp Gerontol

24. LIU D, Yang H, Feng X, Hou M, et al
    Probucol attenuates bone loss in APP/PS1 mice and ameliorates Abeta42-induced osteoblast dysfunction by regulating AKT/FOXO3a signaling pathway.
    Exp Gerontol. 2026;214:113034.
    PubMed         Abstract available
    
    
25. YAO LL, Ma XT, Li FB, Zheng LY, et al
    Correlation between sarcopenia and changes in oligodendrocyte lineage cells in the brains of Alzheimer's disease model mice.
    Exp Gerontol. 2026 Feb 3:113057. doi: 10.1016/j.exger.2026.113057.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

26. AHMED A, Khan H, Shen Y, Xu S, et al
    Neuroprotective potential of Rhus coriaria: Insights into acetylcholinesterase inhibition and amyloid-beta modulation.
    J Alzheimers Dis. 2026;109:1053-1067.
    PubMed         Abstract available
    
    
27. LEE LH, Chou CJ, Shih YC, Fang YM, et al
    Relationship between amyloid burden, cholinergic integrity, and cognitive function.
    J Alzheimers Dis. 2026;109:1319-1330.
    PubMed         Abstract available
    
    
28. HARRIS M, Bateman JR, Shaaban CE, Becker J, et al
    Certainty-weighted recognition memory: Potential applications for early detection and metacognition.
    J Alzheimers Dis. 2026;109:1380-1390.
    PubMed         Abstract available
    
    
29. MICHOPOULOU S, Prosser A, O'Brien N, Dickson J, et al
    Alzheimer's disease diagnosis support for brain perfusion SPECT scans in a real-world clinical cohort.
    J Alzheimers Dis. 2026 Jan 30:13872877251413790. doi: 10.1177/13872877251413790.
    PubMed         Abstract available
    
    
30. GARCIA-CARLOS CA, Salas-Gallardo A, Gonzalez-Pereyra P, Basurto-Islas G, et al
    Amyloid-beta and phosphorylated-tau accumulation in retrosplenial cortex of young Alzheimer's disease model: Impact on network activity.
    J Alzheimers Dis. 2026 Feb 2:13872877261417377. doi: 10.1177/13872877261417377.
    PubMed         Abstract available
    
    
31. CHEN H, Zhang H, Yang M, Xie Q, et al
    Association between apolipoprotein E gene polymorphisms and serum lipid indicators and Alzheimer's disease risk.
    J Alzheimers Dis. 2026 Feb 2:13872877261416064. doi: 10.1177/13872877261416064.
    PubMed         Abstract available
    
    
32. GUO F, Sheng ZH, Li T, Huang LY, et al
    Associations of plasma sphingomyelin SM (d18:1/24:0) with Alzheimer's disease pathology and cognition in non-demented adults.
    J Alzheimers Dis. 2026 Feb 2:13872877251415349. doi: 10.1177/13872877251415349.
    PubMed         Abstract available
    
    
33. EMEKEEVA DD, Chen J, Yang Y, Yang J, et al
    Mapping protein variants associated with Alzheimer's disease by mass-spectrometry based de novo sequencing assisted strategy.
    J Alzheimers Dis. 2026 Feb 3:13872877251414414. doi: 10.1177/13872877251414414.
    PubMed         Abstract available
    
    
34. TRIPANPITAK K, Wolf A, Kapitonova M, Umeda S, et al
    Biomarkers for Alzheimer's disease and mild cognitive impairment: Recent advances in task-based EEG.
    J Alzheimers Dis. 2026 Feb 4:13872877251413700. doi: 10.1177/13872877251413700.
    PubMed         Abstract available
    
    
35. BRENOWITZ WD, Ehrlich JR, Deal JA, Yaffe K, et al
    Introduction to Supplemental Issue: Sensory loss in Alzheimer's disease and related dementias.
    J Alzheimers Dis. 2026 Feb 5:13872877261418685. doi: 10.1177/13872877261418685.
    PubMed         Abstract available
    
    

    
    J Biol Chem

36. TSAKA G, Pages AM, De Sousa CB, Lammertyn J, et al
    Conformation-specific monoclonal antibodies reveal early Tau structural intermediates in Alzheimer's disease.
    J Biol Chem. 2026 Feb 3:111221. doi: 10.1016/j.jbc.2026.111221.
    PubMed         Abstract available
    
    

    
    J Neurol

37. CECCHINI MA, Studart-Neto A, Moraes NC, Carneiro CG, et al
    Short-term memory conjunctive binding in subjective cognitive decline: A PET biomarker-based study.
    J Neurol. 2026;273:107.
    PubMed         Abstract available
    
    

    
    Nat Med

38. HEALEY N
    Blood tests for Alzheimer's disease could reshape research and care.
    Nat Med. 2026 Feb 5. doi: 10.1038/d41591-026-00008.
    PubMed        
    
    

    
    Nature

39. ZETTERBERG H, Bendlin BB
    Biofluid biomarkers in Alzheimer's disease and other neurodegenerative dementias.
    Nature. 2026;650:49-59.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

40. LANZILLOTTA S, Boccardi V, Zulli B, Napoli A, et al
    GDF-11, GDF-15, Jag-1, and leptin in neuronal-derived extracellular vesicles as aging-related biomarkers to identify individuals at risk of Alzheimer's dementia: A pilot study.
    Neurobiol Dis. 2026;220:107291.
    PubMed         Abstract available
    
    

    
    Neurology

41. VRILLON A, Spina S, Mejia-Perez J, Lamore T, et al
    Association of [(18)F]Flortaucipir-PET and Plasma p-Tau217 With Tau Neuropathology in Alzheimer Disease and Other Neurodegenerative Disorders.
    Neurology. 2026;106:e214576.
    PubMed         Abstract available
    
    
42. NELSON PT, Jicha GA
    Tau Biomarker-Based Diagnosis of Alzheimer Disease and the Anti-Abeta Therapeutic Window: Is There Overlap?
    Neurology. 2026;106:e214696.
    PubMed        
    
    
43. HALL BJ, Aumont E, Hosseini SA, Fernandez Arias J, et al
    Association of Cortical Free Water With Brain Tau Tangle Load in the Alzheimer Disease Continuum.
    Neurology. 2026;106:e214606.
    PubMed         Abstract available
    
    

    
    Neuroscience

44. DENVER P, Duffy A, Kennedy RT, Gault VA, et al
    Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer's disease.
    Neuroscience. 2026 Jan 28:S0306-4522(26)00075.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

45. OLCHANYI MD, Schreier DR, Li J, Maffei C, et al
    Probabilistic mapping and automated segmentation of human brainstem white matter bundles.
    Proc Natl Acad Sci U S A. 2026;123:e2509321123.
    PubMed         Abstract available
    
    
46. CEN Y, R Alves S, Song D, Felice C, et al
    PTP1B inhibition promotes microglial phagocytosis in Alzheimer's disease models by enhancing SYK signaling.
    Proc Natl Acad Sci U S A. 2026;123:e2521944123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum